Terms: = Breast cancer AND MAP2K4, MEK4, 6416, P45985, ENSG00000065559, SERK1, JNKK1, MKK4, PRKMK4, MAPKK4, JNKK, SEK1 AND Prognosis
8 results:
1. Selinexor demonstrates anti-tumor efficacy in paired patient-derived xenograft models and hydrogel-embedded histoculture drug sensitivity test of penile cancer.
He Y; Mei J; Hao H; Liu F; Yi Y; Hu C; Zou F; Lu X
J Cancer Res Clin Oncol; 2023 Aug; 149(10):6931-6941. PubMed ID: 36840755
[TBL] [Abstract] [Full Text] [Related]
2. Mammary mucinous cystadenocarcinoma with long-term follow-up: molecular information and literature review.
Lei T; Shi YQ; Chen TB
Diagn Pathol; 2023 Feb; 18(1):13. PubMed ID: 36737820
[TBL] [Abstract] [Full Text] [Related]
3. A novel methuosis inducer DZ-514 possesses antitumor activity via activation of ROS-mkk4-p38 axis in triple negative breast cancer.
Wang L; Mi D; Hu J; Liu W; Zhang Y; Wang C; Chen Y; Chen C
Cancer Lett; 2023 Feb; 555():216049. PubMed ID: 36608865
[TBL] [Abstract] [Full Text] [Related]
4. LncRNA CBR3-AS1 regulates of breast cancer drug sensitivity as a competing endogenous RNA through the JNK1/mek4-mediated MAPK signal pathway.
Zhang M; Wang Y; Jiang L; Song X; Zheng A; Gao H; Wei M; Zhao L
J Exp Clin Cancer Res; 2021 Jan; 40(1):41. PubMed ID: 33494806
[TBL] [Abstract] [Full Text] [Related]
5. Endocrine-responsive lobular carcinoma of the breast: features associated with risk of late distant recurrence.
Conforti F; Pala L; Pagan E; Viale G; Bagnardi V; Peruzzotti G; De Pas T; Bianco N; Graffeo R; Rocco EG; Vingiani A; Gelber RD; Coates AS; Colleoni M; Goldhirsch A
Breast Cancer Res; 2019 Dec; 21(1):153. PubMed ID: 31888717
[TBL] [Abstract] [Full Text] [Related]
6. [Expressions of map2k4 and estrogen receptor and their clinical significance in invasive breast cancer].
Liu S; Liu YY; Li R
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Apr; 37(4):488-493. PubMed ID: 28446401
[TBL] [Abstract] [Full Text] [Related]
7. The landscape of candidate driver genes differs between male and female breast cancer.
Johansson I; Ringnér M; Hedenfalk I
PLoS One; 2013; 8(10):e78299. PubMed ID: 24194916
[TBL] [Abstract] [Full Text] [Related]
8. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups.
Curtis C; Shah SP; Chin SF; Turashvili G; Rueda OM; Dunning MJ; Speed D; Lynch AG; Samarajiwa S; Yuan Y; Gräf S; Ha G; Haffari G; Bashashati A; Russell R; McKinney S; ; Langerød A; Green A; Provenzano E; Wishart G; Pinder S; Watson P; Markowetz F; Murphy L; Ellis I; Purushotham A; Børresen-Dale AL; Brenton JD; Tavaré S; Caldas C; Aparicio S
Nature; 2012 Apr; 486(7403):346-52. PubMed ID: 22522925
[TBL] [Abstract] [Full Text] [Related]
